Concepedia

Carol Waghorne

CW

Statistics

Publications

20

Citations

2.4K

H-Index

16

Active since

1978

Affiliations

Arqule (United States)(Current)

Harvard University

University of Toronto

Boston Children's Hospital

Dalhousie University

Carol Waghorne is an author at Arqule (United States) specializing in oncology, medicine, and metastasis.

Publications per year

1978–2012

20

Publications

20

β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis

James W. Dennis, Suzanne Laferté, Carol Waghorne et al. · Science · 1987 · 940 citations

, , +17

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

Timothy A. Yap, David Olmos, André T. Brunetto et al. · Journal of Clinical Oncology · 2011 · 195 citations · Full text

, , +16

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors

Andrew J. Wagner, John M. Goldberg, Steven G. DuBois et al. · Cancer · 2012 · 155 citations

, , +16

Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential

Mark F. Coughlin, Diane R. Bielenberg, Guillaume Lenormand et al. · Clinical & Experimental Metastasis · 2012 · 126 citations

, , +16

Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Robert S. Kerbel, Carol Waghorne, Mi Man et al. · Proceedings of the National Academy of Sciences · 1987 · 119 citations · Full text

, , +13

1–5 of 20